Prenatal screening results of 1 036 mid-pregnancy women in Shexian County

PAN Ye-qing, ZHANG Jian-an, CHENG Ying-ying, SHU Bei-min, WU Chao

Anhui Journal of Preventive Medicine ›› 2022, Vol. 28 ›› Issue (2) : 117-119.

PDF(844 KB)
PDF(844 KB)
Anhui Journal of Preventive Medicine ›› 2022, Vol. 28 ›› Issue (2) : 117-119. DOI: 10.19837/j.cnki.ahyf.2022.02.008

Prenatal screening results of 1 036 mid-pregnancy women in Shexian County

  • PAN Ye-qing, ZHANG Jian-an, CHENG Ying-ying, SHU Bei-min, WU Chao
Author information +
History +

Abstract

Objective The screening information of 1 036 women in the second trimester of pregnancy in Shexian County were analyzed to understand the risk of fetal morbidity and to provide scientific basis for the prevention of birth defects. Methods Serum β- human chorionic gonadotropin (β-HCG),alpha fetoprotein (AFP) and free estriol (uE3) levels in mid-pregnancy women were detected by chemiluminescence immunoassay.These indicators calculated the risk rate of fetal morbidity by combining maternal age,weight,and gestational weeks. Results Of the 1 036 pregnant women screened,there were 61 cases (5.8%) in the high-risk group,43 cases (4.2%) in the borderline risk group,and 932 cases (90.0%) in the low-risk group.The pregnancy outcomes of 1 010 pregnant women were followed up,with 9 cases of therapeutic induced of labor.The differences of the therapeutic induced labor rates in different risk groups were statistically significance (χ2=9.984,P=0.006).There were 32 cases of combined gestational hypertension in pregnant women.Notably,the detection rate of hypertension in pregnancy was higher in the borderline risk and high risk groups than in the low risk group (χ2=5.432,P=0.045). Conclusion Serological screening in the second trimester of pregnancy has significant effect on the prevention of birth defects.

Key words

Mid pregnancy / Prenatal screening / Birth defect / Risk assessment / Maternal and child health care / Eugenics

Cite this article

Download Citations
PAN Ye-qing, ZHANG Jian-an, CHENG Ying-ying, SHU Bei-min, WU Chao. Prenatal screening results of 1 036 mid-pregnancy women in Shexian County[J]. Anhui Journal of Preventive Medicine. 2022, 28(2): 117-119 https://doi.org/10.19837/j.cnki.ahyf.2022.02.008

References

[1] 朱军.国内外出生缺陷的监测进展[J].实用妇产科杂志,2008,24(1):3-4.
[2] Dai L,Zhu J,Liang J,et al.Birth defects surveillance in China[J].World JPediatr,2011,7(4):302-310.
[3] 房金妍.18 662例孕中期妇女血清学产前筛查结果分析[J].中国妇幼保健,2021,36(24):5758-5760.
[4] 封建凯,曹善楠,王爱玲,等.孕中期唐氏综合征筛查风险预测母胎不良妊娠结局的价值 [J].中国妇幼保健,2021,36(6):1391-1394.
[5] 张明镜,丁显平,杜鹏军,等.某地区7 942例孕中期唐氏综合征筛查结果分析 [J].检验医学与临床,2017,14(4):538-540.
[6] 胡丽花,章金玲,胡兰兰.黄山市2 185名孕中期妇女唐氏综合征产前筛查结果分析[J].安徽预防医学杂志,2020,26(4):320-322.
[7] 中华人民共和国卫生部.《中国出生缺陷防治报告(2012)》[R/OL].(2012-9-12)[2021-9-1].http://www.gov.cn/gzdt/att/att/site1/20120912/1c6f6506c7f811bacf9301.pdf.
[8] Wald NJ,Cuckle HS,Densem JW,et al.Maternal serum screening for Down's syndrome in early pregnancy[J].BMJ,1988,297(6653):883-887.
[9] Lo YM,Corbetta N,Chamberlain PF,et al.Presence of fetal DNA in maternal plasma and serum[J].Lancet,1997,350(9076):485-487.
[10] 谢幸,孔北华,段涛.妇产科学[M].第9版.北京:人民卫生出版社,2018:83-84.
[11] 杨琴,蒋燕,冯虹.妊娠中期f-β-HCG、AFP、uE3及Hcy与妊娠期高血压疾病关系[J].中国计划生育学杂志,2020,28(10):1676-1679.
[12] 王红坤,赵燕玲,徐先明,等.产前筛查结果与不良妊娠结局关系分析[J].现代妇产科进展,2021,30(3):161-166.
[13] 曾敏.孕早期血清学联合NT筛查唐氏综合征高风险与不良妊娠结局的关系[D].南昌:南昌大学,2018.
PDF(844 KB)

Accesses

Citation

Detail

Sections
Recommended

/